Unresectable Retiform Hemangioendothelioma Treated with External Beam Radiation Therapy and Chemotherapy: A Case Report and Review of the Literature

Retiform hemangioendothelioma (RH) is an infrequently encountered vascular neoplasm of intermediate or borderline malignancy. Treatment of RH is controversial. We present a case of a 44-year-old Asian male presenting with an unresectable RH of the pelvis. The patient was treated with concurrent low-...

Full description

Saved in:
Bibliographic Details
Published inSarcoma Vol. 2010; no. 2010; pp. 162 - 164
Main Authors Hirsh, Alina Z., Yan, Weisi, Wei, Lihong, Wernicke, A. Gabriella, Parashar, Bhupesh
Format Journal Article
LanguageEnglish
Published Cairo, Egypt Hindawi Limiteds 2010
Hindawi Puplishing Corporation
Hindawi Publishing Corporation
John Wiley & Sons, Inc
Wiley
Subjects
Cancer
Care and treatment
Case Report
Case studies
Chemotherapy
Diagnosis
Hemangioendothelioma
Patient outcomes
Radiotherapy
United States
Online AccessGet full text

Cover

More Information
Summary:Retiform hemangioendothelioma (RH) is an infrequently encountered vascular neoplasm of intermediate or borderline malignancy. Treatment of RH is controversial. We present a case of a 44-year-old Asian male presenting with an unresectable RH of the pelvis. The patient was treated with concurrent low-dose Cisplatin and External beam Radiation (4140cGy in 180cGy per fraction). This is the first report of a clinical complete response and a long-term local control of this rare tumor. This has significant clinical implication, since it gives the first evidence of treatment of this rare tumor using concurrent low-dose chemotherapy and radiation.
Bibliography:Academic Editor: Alberto Pappo
ISSN:1357-714X
1369-1643
DOI:10.1155/2010/756246